Exploring prognostic factors in patients achieving PCR after neoadjuvant therapy for triple-negative breast cancer: A retrospective study based on SEER data

被引：0
|
作者：
Wenjie, L. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Breast Surg, Sch Med, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
38P
引用
收藏
页码：S1480 / S1480
页数：1
相关论文
共 50 条
  • [1] Prognostic factors for cancer-specific survival in pCR patients with triple-negative breast cancer after neoadjuvant therapy: a SEER-based retrospective study
    Lv, W.
    Wu, P.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 31 - 31
  • [2] Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
    Li, Zhijun
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [3] Prognostic factors in triple-negative breast cancer: a retrospective cohort
    Assuncao Ribeiro da Costa, Rafael Everton
    Rocha de Oliveira, Fergus Tomas
    Nascimento Araujo, Ana Lucia
    Vieira, Sabas Carlos
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (07): : 950 - 957
  • [4] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Feng Ding
    Ru-Yue Chen
    Jun Hou
    Jing Guo
    Tian-Yi Dong
    World Journal of Clinical Cases, 2022, 10 (12) : 3698 - 3708
  • [5] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Ding, Feng
    Chen, Ru-Yue
    Hou, Jun
    Guo, Jing
    Dong, Tian-Yi
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3698 - 3708
  • [6] BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study
    Kosaka, Y.
    Yamamoto, Y.
    Nishimiya, H.
    Ibusuki-Yamamoto, M.
    Hirota, Y.
    Tanino, H.
    Iwase, H.
    Nakamura, S.
    Akashi-Tanaka, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [7] The prognosis of effectiveness neoadjuvant therapy in patients with triple-negative breast cancer
    Vyzhigina, B.
    BREAST, 2019, 44 : S67 - S67
  • [8] BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
    Kosaka, Yoshimasa
    Yamamoto, Yutaka
    Tanino, Hirokazu
    Nishimiya, Hiroshi
    Yamamoto-Ibusuki, Mutsuko
    Hirota, Yuko
    Iwase, Hirotaka
    Nakamura, Seigo
    Akashi-Tanaka, Sadako
    DIAGNOSTICS, 2020, 10 (02)
  • [9] Prognostic Impact of Residual Disease After Neoadjuvant Chemotherapy in 648 Patients with Triple-negative Breast Cancer
    Kern, Peter
    Von Minckwitz, Gunter
    Puetter, Carolin
    Pavlidou, Sofia
    Flach, Annika
    Kimmig, Rainer
    Rezai, Mahdi
    ANTICANCER RESEARCH, 2015, 35 (10) : 5479 - 5484
  • [10] Prognostic Value of Immunohistochemistry-based Subtyping Before and After Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer
    Wu, Long
    Chen, Minyan
    Lin, Yuxiang
    Zeng, Bangwei
    Guo, Wenhui
    Chen, Lili
    Li, Yan
    Yu, Liuwen
    Li, Jing
    Chen, Xiaobin
    Zhang, Wenzhe
    Li, Shengmei
    Cai, Weifeng
    Zhang, Kun
    Jin, Xuan
    Huang, Jianping
    Lin, Qili
    Yang, Yinghong
    Fu, Fangmeng
    Wang, Chuan
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (01) : 27 - 35
12345